Skip to content

AML/CTF Regulatory Round Up – June 2024

Market Insights

This year has seen a number of developments in Australia’s anti-money laundering and counter-terrorism financing (AML/CTF) regulatory landscape.

We explore these developments and more in this AML/CTF regulatory round up. In this edition, we cover:

  • The second stage of consultation on the AML/CTF reforms:
    • Part 1: Incorporation of Tranche 2 entities (click here to read);
    • Part 2: Further details released on proposed reforms to simplify, clarify, and modernise Australia’s AML/CTF regime (click here to read);
  • AUSTRAC’s draft guidance around outsourcing arrangements released for consultation (click here to read);
  • An update about recent and ongoing enforcement activity (click here to read); and
  • A summary of AUSTRAC’s regulatory priorities for 2024 (click here to read).

If you have any queries or need any assistance in relation to the AML/CTF reforms, compliance or any issues more generally, please contact a member of our team.

This newsletter was written by Polat Siva, Partner, Neil Perl, Special Counsel, Vesa Prekazi, Special Counsel, Gabriel Hawkins, Associate, Rebecca Young, Associate.

Important Disclaimer: The material contained in this publication is of general nature only and is based on the law as of the date of publication. It is not, nor is intended to be legal advice. If you wish to take any action based on the content of this publication we recommend that you seek professional advice.

Subscribe for publications + events

HWLE regularly publishes articles and newsletters to keep our clients up to date on the latest legal developments and what this means for your business. To receive these updates via email, please complete the subscription form and indicate which areas of law you would like to receive information on.

* indicates required fields

This field is for validation purposes and should be left unchanged.
Interests **
This field is hidden when viewing the form
Email preferences*
What type of content would you like to receive from us?